Development and preliminary evaluation of a multivariate index assay for ovarian cancer. - Wikidata - awgldk - TriplyDB

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

http://www.wikidata.org/entity/Q30858808

about

In 2014, can we do better than CA125 in the early detection of ovarian cancer?Insidious changes in stromal matrix fuel cancer progression Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers Data Analysis Strategies for Protein Microarrays.Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.Challenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data.Protein biomarkers of ovarian cancer: the forest and the trees Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.Potential markers for detection and monitoring of ovarian cancer.Current state of biomarker development for clinical application in epithelial ovarian cancer.Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women.Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers.Ovarian cancer: in search of better marker systems based on DNA repair defects Biomarker testing for ovarian cancer: clinical utility of multiplex assays Raised circulating tenascin-C in rheumatoid arthritis.ITIH3 is a potential biomarker for early detection of gastric cancer.Serum protein profile at remission can accurately assess therapeutic outcomes and survival for serous ovarian cancer.Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.Rapid emergence of multimarker strategies in laboratory medicine.Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.

P2860

Q26825152-750613E6-76E4-409E-8A2A-53E09A95BE8A Q26851261-7B35A3D8-1ABE-4B10-B890-588B971BACEC Q28741004-D17C91AB-BF0E-4E1F-9C8A-81D8835F9C3B Q31127442-9DB3399F-613A-4E79-8F52-29CA36E371AF Q34315258-DFAE1A8C-EE95-4A38-AC64-7284AA9D73E2 Q34555631-E8A33062-6D79-4E68-B824-960EC394D544 Q34634143-32CF652A-CEAF-4BBA-BCA5-1DDAC6033B19 Q34887528-BC626180-66FA-46FA-BC9E-3C2CE5B3DB58 Q34960174-BF610981-C215-4643-AD96-EC4F8BAB0A9A Q35100951-6CDC7FA1-8A6D-4533-B294-0A3108BD67A3 Q35208879-7BAED93F-161B-41D1-8E56-097C648FD43A Q35612779-9D9DFC38-07D5-4DB9-ACC2-CFD9FF41679B Q35922723-9A0D0556-A281-434C-9131-E3C2E4C6EC36 Q36556482-54111FC5-BAFB-499C-8DC7-1FEBBE163994 Q36589947-64FF92FC-DA34-4BED-86D7-8457236A8459 Q36897149-E92373A8-5562-4790-A04E-2A737C6A3E18 Q36907720-AA779BE1-2DA9-4D11-9C70-C9D8FEDB5828 Q37139950-79FCE50B-15AE-4BCD-A06F-D7A0163AF671 Q37297487-F20026AC-8463-4D43-8F22-5A5DB59B8CEA Q37313286-5F7AD3B2-9B60-41E9-9D71-84FC995CC23A Q37680975-A3C5BA16-4018-4ABF-8378-B4A83A7C2E3B Q38100809-9B4F730A-62FB-410B-9FD4-7AF379699FBB Q52639657-90C154D0-74DE-4C51-AD63-530E0AC08743

P2860

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

http://www.wikidata.org/entity/Q30858808

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

@ast

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

@en

type

label

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

@ast

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

@en

prefLabel

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

@ast

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

@en

P1433

Q30858808-45E49DEB-35B4-4B37-ADE1-13232C63A3F0

P1476

Q30858808-EA9769F2-CE76-49E0-B7F5-94B1B3A7E3FD

P2093

Q30858808-2A30EE3F-9524-4D89-9EF2-CB8FFB850D80

Q30858808-429BD3C7-86BF-42C2-8F17-F10A78C7DDC2

Q30858808-74DDBA66-A5D1-404D-85FB-F96E5A91E752

Q30858808-8B9A4C20-A871-42F0-8633-7B2FFCF12BF8

Q30858808-91E5ABA7-FD5C-42EF-B61E-8420823C04C2

Q30858808-A28C0391-F1E5-4BE8-9586-9CA21ED58BD9

Q30858808-F88AF33C-47BC-48DD-B428-69ADFE2818BF

P2860

Q30858808-266E7302-08C9-47BC-809B-1ECF47FF14E1

Q30858808-31B90461-2701-41C6-905C-2E8848AC77BE

Q30858808-45EC1622-710F-40DE-A1E0-9FB03E256E25

Q30858808-5812BAB8-666C-4C0E-A3D0-D5AE2E418974

Q30858808-63836745-CAAA-4CFC-A550-04798E72E2BA

Q30858808-6B63B66E-DD13-492C-8B47-5AFCCC04F99E

Q30858808-A20D4AEE-F569-483D-B3DE-8DB70319E75D

Q30858808-AD525F46-F3B4-4FEA-BE3D-73020736C302

Q30858808-B72CEA57-59EB-4623-934E-0DA5A290BB24

Q30858808-B8B754B8-73EF-4B58-996D-16CD28AEA57D

P304

Q30858808-E14FEAAE-6558-4B3F-A133-0B1CF094EB5B

P31

Q30858808-7D327551-81F2-44F6-9E72-78287552AAF3

P356

Q30858808-C6A7C0FA-A24D-490C-A44B-B3E3E8DDCE4D

P407

Q30858808-79F2A30C-A638-4473-BAA2-D3F5A0E79D91

P433

Q30858808-6B21858A-EFE0-4D28-A370-9DEF127D784D

P478

Q30858808-83F04CA6-A55E-432C-A692-C8A920819DD4

P50

Q30858808-38C8730E-15E0-4264-84A2-D776F292DB3F

P577

Q30858808-C1208981-32D8-441B-8759-67BE4C598CFC

P5875

Q30858808-79F93FDC-4A5B-40F4-9BD7-CC8C42D0CEF6

P698

Q30858808-C30E0518-334A-4446-8179-8EBB84A0C286

P921

Q30858808-3A69DADA-2329-4EA2-8662-160577EE5274

P932

Q30858808-828798FA-2975-4AE6-BFC2-0AA0C5C9B4FD

P356

JOURNAL.PONE.0004599

P1433

P1476

Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

@en

P2093

Greg P Bertenshaw

http://www.w3.org/2001/XMLSchema#string

Jinghua Zhao

http://www.w3.org/2001/XMLSchema#string

Katharine J Bergstrom

http://www.w3.org/2001/XMLSchema#string

Partha Seshaiah

http://www.w3.org/2001/XMLSchema#string

Ping Yip

http://www.w3.org/2001/XMLSchema#string

Suraj D Amonkar

http://www.w3.org/2001/XMLSchema#string

Tzong-Hao Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Two-sided confidence intervals for the single proportion: comparison of seven methods

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study

Use of proteomic patterns in serum to identify ovarian cancer.

Systematic evaluation of candidate blood markers for detecting ovarian cancer.

Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.

Validation of referral guidelines for women with pelvic masses.

Surveillance of women at high risk for hereditary ovarian cancer is inefficient.

Management of adnexal mass.

Combining a symptoms index with CA 125 to improve detection of ovarian cancer.

P304

e4599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0004599

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Brian C Mansfield

P577

2009-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24038248

http://www.w3.org/2001/XMLSchema#string

P698

19240799

http://www.w3.org/2001/XMLSchema#string

P921

P932

2643010

http://www.w3.org/2001/XMLSchema#string